Why Ardelyx Stock Is Getting Crushed Today

What happened
Shares of the small-cap biotech Ardelyx(NASDAQ:ARDX) fell by a whopping 73.2% in pre-market action Tuesday morning. The drugmaker’s stock is tanking today in response to a July 13 letter from the U.S. Food and Drug Administration regarding…

Click here to view the original article.